List of SBIR/STTR awards granted to Angion Biomedica Corp.
Angion Biomedica Corp.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Angion Biomedica Corp. in April, 2019 for $220,731.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK121642-01 | Phase I | 220,731 | April 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. in September, 2017 for $219,546.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK116452-01 | Phase I | 219,546 | September 15, 2017 | |||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. in April, 2016 for $1,320,083.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK095625-02A1 | Phase II | 1,320,083 | April 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. in September, 2017 for $222,670.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK116404-01 | Phase I | 222,670 | September 15, 2017 | |||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. in January, 2014 for $149,761.0 USD from the National Science Foundation. | SBIR | 1345892 | Phase I | 149,761 | January 1, 2014 | |||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $1,664,290.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK066654-05 | Phase II | 1,664,290 | ||||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $2,979,147.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AA015223-04 | Phase II | 2,979,147 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $234,658.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL091688-01 | Phase I | 234,658 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $215,956.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR054996-01 | Phase I | 215,956 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $295,467.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL088800-01A2 | Phase I | 295,467 | ||||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $942,288.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS053152-02 | Phase II | 942,288 | ||||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $1,194,283.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS045373-04 | Phase II | 1,194,283 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $380,911.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK095625-01A1 | Phase I | 380,911 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $251,048.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AA021054-01A1 | Phase I | 251,048 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $354,104.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL112415-01A1 | Phase I | 354,104 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $269,158.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AA020163-01A1 | Phase I | 269,158 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $311,292.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK085781-01 | Phase I | 311,292 | ||||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $1,859,167.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL062048-02A1 | Phase II | 1,859,167 | ||||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $1,335,726.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK078455-02 | Phase II | 1,335,726 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $290,570.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK078455-01A2 | Phase I | 290,570 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $183,826.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA128164-01 | Phase I | 183,826 | ||||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $2,176,570.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS062625-02 | Phase II | 2,176,570 | ||||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $2,914,840.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL091699-02A2 | Phase II | 2,914,840 | ||||||||
A SBIR Phase I contract was awarded to Angion Biomedica Corp. for $238,482.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AA019876-01 | Phase I | 238,482 | ||||||||
A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $1,874,410.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL076959-02A1 | Phase II | 1,874,410 |
